0001365618-12-000004.txt : 20120913 0001365618-12-000004.hdr.sgml : 20120913 20120913182212 ACCESSION NUMBER: 0001365618-12-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120911 FILED AS OF DATE: 20120913 DATE AS OF CHANGE: 20120913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hove Anders D CENTRAL INDEX KEY: 0001365618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 121090989 MAIL ADDRESS: STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508 CITY: NEW YORK STATE: NY ZIP: 10112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals Inc CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2012-09-11 0001411158 Anacor Pharmaceuticals Inc ANAC 0001365618 Hove Anders D C/O VENROCK 3340 HILLVIEW AVE. PALO ALTO CA 94304 1 0 1 0 Common Stock 2012-09-11 4 S 0 10177 6.6427 D 3794808 I By Funds and LLC's Common Stock 2012-09-13 4 S 0 15000 6.5553 D 3779808 I By Funds and LLC's Consists of 1,721,350 shares held by Venrock Associates IV, L.P. ("VA4"), 351,036 shares held by Venrock Partners, L.P. ("VP"), 42,293 shares held by Venrock Entrepreneurs Fund IV, L.P. ("VEF4"), 1,361,755 shares held by Venrock Healthcare Capital Partners, L.P. ("VHCP"), 249,101 shares held by VHCP Co-Investment Holdings LLC ("VHCP Co-Invest"), 46,092 shares held by Venrock Associates V, L.P. ("VA5"), 3,908 shares held by Venrock Partners V, L.P. ("VP5"), 5,663 shares held by Venrock Management IV, LLC ("VM4"), 1,193 shares held by Venrock Partners Management, LLC ("VPM"), 82 shares held by VEF Managment IV, LLC ("VEFM4") and 12,335 shares held by VHCP Management, LLC ("VHCP Management"). VM4, VPM, VEFM4 are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Venrock Management V, LLC ("VM5") and Venrock Partners Management V, LLC ("VPM5") are the sole general partners of VA5 and VP5, respectively, and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM, VEFM4, VM5 and VPM5 and a managing member of VHCP Management. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VA5, VP5, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4, VM5, VPM5 and VHCP Management except to the extent of his indirect pecuniary interest therein. Consists of 1,721,350 shares held by VA4, 351,036 shares held by VP, 42,293 shares held by VEF4, 1,361,755 shares held by VHCP, 249,101 shares held by VHCP Co-Invest, 32,265 shares held by VA5, 2,735 shares held by VP5, 5,663 shares held by VM4, 1,193 shares held by VPM, 82 shares held by VEFM4 and 12,335 shares held by VHCP Management. /s/ Anders D. Hove 2012-09-13